Drug Development Database| Pharma R&D| Pharmaprojects

Follow company pipelines in over 40 countries and probe more than 30 years of R&D history to uncover trends that have, and will, impact the drug development industry.

How it works

Pharmaprojects provides comprehensive coverage of drug development, from discovery to end of patent and market exclusivity. Its intuitive search interface supports quick access to disease-, company-, or country-specific drug development results. These can be visualized quickly via an analytic dashboard, or exportable into several formats.

How it can help

Pharmaprojects' expert analysts track in- and out-licensing acitivity making it easy to identify opportunities or market saturation.These analysts will conduct primary research on your behalf to try to uncover additional information around your drug or company of interest. And, the deep linking to Trialtrove means that you will be on top of any clinical trial developments for your disease, company, or therapeutic mechanism of interest.

Pharmaprojects

Statins Forever Infographic

12 Jun 2017

This informative visual gives you a snapshot view of the current dyslipidemia market and the drugs poised to challenge the unparalleled reign of statins.

Pharmaprojects, Sitetrove, Trialtrove

R and D Annual Review Webinar 2017

19 Apr 2017

The R&D Annual Review webinar is happening soon. Take a look back at pharma R&D in 2016 and look ahead to the remainder of the year to get expert insight from the senior experts at Pharma Intelligence during this free webinar.

Pharmaprojects

Cystic Fibrosis Awareness

By Loni Branon 13 Apr 2017

A Look At Prevalence and Current Clinical Trial Activity – Is There More We Could Be Doing?

Pharmaprojects

Pharma R and D Annual Review 2017 Supplement

By Ian Lloyd 13 Apr 2017

Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.

Pharmaprojects

Pharma R&D By Numbers

By Ian Lloyd 22 Mar 2017

Welcome to Pharmaprojects' 2017 review of trends in pharmaceutical R&D.

Pharmaprojects, Biomedtracker, Trialtrove

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

By Rachel Meighan-Mantha 22 Mar 2017

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

Pharmaprojects

Statins forever: Is anything set to topple this class’s mighty reign?

22 Mar 2017

With the recent controversy surrounding the approval and launch of the first wave of PCSK9 inhibitors (focussing mainly on the extremely high cost in comparison to statin therapies), it may be easy to forget that the dyslipidaemia space has also been plagued by a number of high profile and costly failures too.

Pharmaprojects

Discover A Bird’s-Eye View of the Rare Disease Landscape below

27 Feb 2017

Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.

Pharmaprojects

The evolution of clinical research in East Asia

By Roger Longman 25 Nov 2016

Citeline Doro's analyzes the increased activity of clinical trials located in East Asia. This report gives a detailed look into characteristics of trials currently being conducted and planned in East Asia.

Pharmaprojects

Announcing the Clinical and Research Excellence Awards and a call for nominations

By Doro Shin 25 Jan 2016

On April 27, 2016, Informa will host its inaugural Clinical and Research Excellence (CARE) Awards to honor those in clinical R&D who are making a difference and committed to making human lives better.

Pharmaprojects

Upcoming Novel HIV Single Tablet Regimens

By Benjamin Graham 01 Dec 2015

For World AIDS Day, we look at current and upcoming novel single tablet regimens (STRs) for HIV treatment. STR’s primary advantage is that they simplify treatment and this leads to greater patient adherence, lower resistance emergence and overall improved outcomes over more traditional cocktails of antiretroviral drugs

Pharmaprojects

Prostate Cancer Still A Common Occurrence

By Jonathan Stephens 24 Nov 2015

When considering cancer in men, prostate cancer could be described as ‘all too frequent’. Indeed, the annual month of ‘Movember’ is here once again and serves as a stark reminder that men worldwide are still dying too young from this disease.Worldwide prostate cancer is currently the second most common cancer in males and the fourth most common cancer overall, with over 1.1 million new cases diagnosed in 2012

Pharmaprojects

PCSK9 Inhibitors What does the future hold for this controversial new class

By Natasha Boliter 28 Oct 2015

With the recent launch of Regeneron/Sanofi’s Praluent® and Amgen’s Repatha®, which are both fully human anti-PCSK9 monoclonal antibodies, it is interesting to consider the other molecular approaches being pursued in the burgeoning PCSK9 inhibitor arena.

Pharmaprojects

Anticancer Immunotherapy - A New Weapon Against Cancer

By Jonathan Stephens 06 Jul 2015

Since its inception in the mid-20th century, chemotherapy has been the mainstay of cancer treatment and has become increasingly specific and effective.

Pharmaprojects

Part 2 Current Status of Ebola Virus Treatments

By Benjamin Graham 25 Mar 2015

Continuing from part 1 of this series (https://citeline.com/part-1-current-status-ebola-vaccine-development/), which addressed the clinical development of a vaccine for Ebola virus disease (EVD), part 2 will be assessing the status of treatments for EVD.

Complete drug tracking

What's included

Below are the Feature List

Robust, curated content

Drug R&D landscape

Historical trends

Ask the Analyst

Dynamic visual results

Pharma Intelligence: latest

Statins Forever Infographic

R and D Annual Review Webinar 2017

Cystic Fibrosis Awareness

Pharma R and D Annual Review 2017 Supplement

Pharma R&D By Numbers

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

Statins forever: Is anything set to topple this class’s mighty reign?

Discover A Bird’s-Eye View of the Rare Disease Landscape below

The evolution of clinical research in East Asia

Announcing the Clinical and Research Excellence Awards and a call for nominations

Upcoming Novel HIV Single Tablet Regimens

Prostate Cancer Still A Common Occurrence

PCSK9 Inhibitors What does the future hold for this controversial new class

Anticancer Immunotherapy - A New Weapon Against Cancer

Part 2 Current Status of Ebola Virus Treatments

Meet the team

Below are the Analyst Profile

Ian Lloyd

Management, Senior Director

Karen Currie

Management, Executive Director, Editorial

Patricia Reilly

Management, Vice President, Intelligence Alliances and Product Unification

Trialtrove

Sitetrove

Clinical and Research Excellence

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Report store

Pharmaprojects

​Complete drug tracking

What's included

Below are the Feature List

​Robust, curated content

Drug R&D landscape

Historical trends

Ask the Analyst

Dynamic visual results

Pharma Intelligence: latest

Meet the team

Below are the Analyst Profile

Ian Lloyd

Management, Senior Director

Karen Currie

Management, Executive Director, Editorial

Patricia Reilly

Management, Vice President, Intelligence Alliances and Product Unification

Related Products

Trialtrove

Sitetrove

Clinical and Research Excellence

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Report store

Complete drug tracking

Robust, curated content